🇨🇦 Xenon Pharmaceuticals Inc.
Forum topic · XENE · Company page: financials, ownership and filings
Join the discussion on Xenon Pharmaceuticals Inc.
Loading…
Results announced on 9 November 2026
Xenon Pharmaceuticals Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $110 million.
Mutual funds: 279 funds hold $2.3 billion
279 mutual funds in 2 countries hold shares of Xenon Pharmaceuticals Inc. worth $2.3 billion, about 38.5% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 176 funds added shares and 80 sold; on balance they bought $221 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.